Digbi Cares
Commercial- Indications
- Prediabetes, Type 2 diabetes, PCOS, Hypertension, Gastrointestinal disorders, Obesity
Company intelligence / Profile preview
Digbi Health offers a commercial digital therapeutics platform that uses AI to integrate genetic data, gut microbiome analysis, behavioral signals, and continuous glucose monitoring. Their programs are designed to address obesity, cardiometabolic disease, digestive disorders, and related mental health issues. Published research supports efficacy in weight loss and symptom reduction for GI/mental health conditions. The company has FDA authorization for its anxiety/depression solution linked to gut health.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Digbi Health.